| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$52 |
Bell Potter Healthcare conference presentation
|
19 Nov 2025 8:32AM |
$0.450 |
$0.465 |
risen by
3.33%
|
|
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$148 |
2025 AGM Chair Address and Presentation
|
19 Nov 2025 8:32AM |
$0.330 |
$0.345 |
risen by
4.55%
|
|
| FSA Group Limited (FSA) ORDINARY FULLY PAID |
Financials |
$160 |
Update - Notification of buy-back - FSA
|
19 Nov 2025 8:32AM |
$1.185 |
$1.280 |
risen by
8.02%
|
|
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,146 |
Update - Notification of buy-back - DUI
|
19 Nov 2025 8:32AM |
$5.220 |
$5.330 |
risen by
2.11%
|
|
| Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$182 |
Decidr To Enter US Market with Acquisition of Sugarwork, Inc
|
19 Nov 2025 8:32AM |
$0.680 |
$0.585 |
fallen by
13.97%
|
|
DAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Decidr AI Industries Ltd to acquire 100% of Sugarwork, Inc.
- Sugarwork specializes in AI knowledge transfer and workflow automation.
- The acquisition facilitates Decidr's entry into the US market.
- Transaction structured as a scrip-for-scrip equity swap.
- Sugarwork's customer base spans finance, healthcare, and industrial sectors.
- The acquisition supports Decidr's mission to expand its Agentic AI platform.
- Integration aims to enhance AI workflow monetization and adoption.
- Transaction completion subject to customary closing conditions.
- Investor webinar scheduled to discuss the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$25 |
Application for quotation of securities - QFE
|
19 Nov 2025 8:32AM |
$0.125 |
$0.065 |
fallen by
48%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$88,734 |
Update - Notification of buy-back - CSL
|
19 Nov 2025 8:32AM |
$180.080 |
$182.900 |
risen by
1.57%
|
|
| Medibank Private Limited (MPL) ORDINARY FULLY PAID |
Financials |
$13,192 |
2025 AGM Chair and CEO Address
|
19 Nov 2025 8:31AM |
$4.810 |
$4.790 |
fallen by
0.42%
|
|
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Distribution Agreement with Japanese matcha manufacturer
|
19 Nov 2025 8:31AM |
$0.011 |
$0.010 |
fallen by
9.09%
|
|
OMG - Price-sensitive ASX Announcement
Full Release
Key Points
- OMG Group Limited has entered into a five-year exclusive distribution agreement with SANDAI, a premium matcha manufacturer from Nagasaki, Japan.
- The agreement involves the supply of 350,000kg of ceremonial-grade matcha per year.
- OMG Group will use a multi-channel strategy to distribute SANDAI matcha in Australia and internationally.
- The matcha market is valued at US$4.3Bn in 2023, expected to grow to US$7.43Bn by 2030.
- OMG Group plans to launch new matcha-infused products and act as a wholesale distributor.
- The company aims to leverage existing networks in grocery chains, cafes, and ecommerce channels.
- OMG's CEO emphasizes the strategic significance of this agreement for high-margin sales growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$200 |
Update - Notification of buy-back - CAA
|
19 Nov 2025 8:31AM |
$11.490 |
$12.240 |
risen by
6.53%
|
|
| Warriedar Resources Limited (WA8) ORDINARY FULLY PAID |
Materials |
$333 |
Ceasing to be a substantial holder
|
19 Nov 2025 8:31AM |
$0.265 |
$0.265 |
fallen by
0%
|
|
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,170 |
Update - Notification of buy-back - LFSPA
|
19 Nov 2025 8:30AM |
$1.130 |
$1.125 |
fallen by
0.44%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$79 |
Cyclopharm Bell Potter Healthcare Conference Presentation
|
19 Nov 2025 8:30AM |
$0.665 |
$0.710 |
risen by
6.77%
|
|
CYC - Price-sensitive ASX Announcement
Full Release
Key Points
- Cyclopharm Limited aims for 250-300 Technegas installations in the U.S. by second half CY2026.
- Technegas offers high diagnostic accuracy and low radiation exposure.
- Expansion into chronic respiratory diseases market, such as COPD and asthma.
- Significant presence in 66 countries with plans to leverage AI and analytical software.
- U.S. sales force expansion and strong pipeline of revenue-generating sites.
- Focus on recurring revenue through consumable sales and annual access fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$1,575 |
Becoming a substantial holder
|
19 Nov 2025 8:30AM |
$0.585 |
$0.600 |
risen by
2.56%
|
|
| SEEK Limited (SEK) ORDINARY FULLY PAID |
Communication Services |
$8,684 |
SEEK Chairman Succession
|
19 Nov 2025 8:30AM |
$24.620 |
$24.310 |
fallen by
1.26%
|
|
| Brookside Energy Limited (BRK) ORDINARY FULLY PAID |
Energy |
$44 |
Update - Notification of buy-back - BRK
|
19 Nov 2025 8:30AM |
$0.400 |
$0.455 |
risen by
13.75%
|
|
| Lynas Rare Earths Limited (LYC) ORDINARY FULLY PAID |
Materials |
$15,098 |
Ceasing to be a substantial holder
|
19 Nov 2025 8:29AM |
$14.620 |
$15.000 |
risen by
2.60%
|
|
| Nexus Minerals Limited (NXM) ORDINARY FULLY PAID |
Materials |
$45 |
Company Presentation - Mines in the Vines
|
19 Nov 2025 8:29AM |
$0.078 |
$0.074 |
fallen by
5.13%
|
|
| Altair Minerals Limited (ALR) ORDINARY FULLY PAID |
Materials |
$119 |
Change in substantial holding
|
19 Nov 2025 8:29AM |
$0.022 |
$0.020 |
fallen by
9.09%
|
|
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$29 |
Update - Notification of buy-back - CDO
|
19 Nov 2025 8:29AM |
$1.860 |
$1.810 |
fallen by
2.69%
|
|
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
EVE Signs Telehealth Services Agreement with hubMed
|
19 Nov 2025 8:29AM |
$0.026 |
$0.025 |
fallen by
3.85%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- EVE Health Group Limited has entered into a Patient Support Telehealth Services Agreement with hubMed Pty Ltd.
- The agreement focuses on a National Patient Support Program for patients prescribed EVE’s products for women’s and men’s health conditions.
- The program aims to expand EVE’s telehealth partners following the launch of Dyspro™ and the upcoming launch of Libbo™.
- It is designed to enhance continuity of care and patient confidence during treatment.
- Patients will have access to telehealth consultations with independent clinicians.
- The program will support conditions like dysmenorrhoea and erectile dysfunction.
- EVE’s CEO emphasized the importance of reliable follow-up and clinical support for overlooked health conditions.
- hubMed will provide regular Registered Nurse touchpoints and communication with usual treating practitioners.
- The initiative aims to improve adherence, symptom management, and clinical guidance.
- EVE is expanding its digital ecosystem for patient support across both women’s and men’s health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,716 |
Response to Acquisition Speculation
|
19 Nov 2025 8:29AM |
$12.410 |
$12.710 |
risen by
2.42%
|
|
| Nuix Limited (NXL) ORDINARY FULLY PAID |
Information Technology |
$638 |
AGM 2025 Chairman and Interim CEO Addresses, Trading Update
|
19 Nov 2025 8:29AM |
$1.860 |
$1.905 |
risen by
2.42%
|
|
NXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Nuix Limited held its 2025 AGM in Sydney, Australia.
- The Interim CEO John Ruthven delivered a trading update and strategic overview.
- Annualised Contract Value (ACV) increased by 12.1% to $230 million.
- Nuix Neo ACV grew by 144% to $35.8 million.
- A shift towards platform sales and longer procurement cycles were noted.
- Net cash position was strong at $50.7 million by end of October.
- Nuix is focusing on transitioning to a solution-led business with Nuix Neo.
- Strategic focus on aligning pricing with platform strategy.
- The Board is actively seeking a permanent CEO following Jonathan Rubinsztein’s departure.
- Nuix is involved in ongoing legal proceedings with ASIC.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lark Distilling Co. Ltd (LRK) ORDINARY FULLY PAID |
Consumer Staple |
$68 |
2025 Annual General Meeting Chair Address & Presentation
|
19 Nov 2025 8:28AM |
$0.700 |
$0.640 |
fallen by
8.57%
|
|
LRK - Price-sensitive ASX Announcement
Full Release
Key Points
- 12% growth in net sales to $15.6 million
- 6% increase in gross profit to $10.0 million
- Strategic partnership with Seppeltsfield Wines for barrel supply
- Successful equity raising for brand and infrastructure investment
- Completion of Lark brand restage for market expansion
- Strong international sales momentum, especially in Asia
- Stuart Gregor to become CEO in January 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ora Banda Mining Ltd (OBM) ORDINARY FULLY PAID |
Materials |
$2,437 |
Becoming a substantial holder
|
19 Nov 2025 8:28AM |
$1.150 |
$1.280 |
risen by
11.30%
|
|